Literature DB >> 31772073

Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.

Mark Yarchoan, Parul Agarwal, Augusto Villanueva, Shuyun Rao, Laura Dawson, Thomas Karasic, Joseph Llovet, Richard Finn, John Groopman, Hashem El-Serag, Satdarshan Monga, Xin Wei Wang, Michael Karin, Robert Schwartz, Kenneth Tanabe, Lewis Roberts, Preethi Gunaratne, Allan Tsung, Kimberly Brown, Theodore Lawrence, Riad Salem, Amit Singal, Amy Kim, Atoosa Rabiee, Linda Resar, Jeffrey Meyer, Yujin Hoshida, Aiwu Ruth He, Kalpana Ghoshal, Patrick Ryan, Elizabeth Jaffee, Chandan Guha, Lopa Mishra, Norman Coleman, Mansoor Ahmed.   

Abstract

Entities:  

Year:  2019        PMID: 31772073     DOI: 10.1158/0008-5472.CAN-19-2958

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


× No keyword cloud information.
  3 in total

1.  Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.

Authors:  Shuang Wu; Guifang He; Shihai Liu; Yongxian Cao; Chao Geng; Huazheng Pan
Journal:  Int J Med Sci       Date:  2022-03-21       Impact factor: 3.642

Review 2.  The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications.

Authors:  Muhammad Sajid; Lianxin Liu; Cheng Sun
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

3.  The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.

Authors:  Lunxu Li; Shilin Xia; Xueying Shi; Xu Chen; Dong Shang
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.